Application of 374554-89-9, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 374554-89-9, name is 3-Chloro-6-fluorobenzo[d]isoxazole, introducing its new discovery.
Pyrazolopyridine derivatives useful in treating inflammation and allergic conditions
A compound of formula (I) or a salt thereof: STR1 wherein: R1 is hydrogen, C1-6 alkyl or phenyl optionally substituted by halogen, CF3, C1-4 alkoxy or C1-4 alkyl; R2 is hydrogen or C1-6 alkyl; R3 is C2-10 alkenyl or C1-10 alkyl substituted by hydroxy, C1-4 alkoxy, thiol, C1-4 alkylthio or NR7 R8 wherein R7 and R8 are independently hydrogen or C1-6 alkyl or together are C3-6 polymethylene; R4 and R5 are independently hydrogen or C1-4 alkyl; and R6 is hydrogen; or C1-4 alkyl or benzyl attached at nitrogen atom 1 or 2; having anti-inflammatory and/or anti-allergy activity.
A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 374554-89-9
Reference£º
Benzisoxazole – Wikipedia,
Benzisoxazole – an overview | ScienceDirect Topics